435 related articles for article (PubMed ID: 24621122)
21. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Ma L; Dou HL; Huang YM; Lu XR; Xu XR; Qian F; Zou ZY; Pang HL; Dong PC; Xiao X; Wang X; Sun TT; Lin XM
Am J Ophthalmol; 2012 Oct; 154(4):625-634.e1. PubMed ID: 22835510
[TBL] [Abstract][Full Text] [Related]
22. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
23. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.
Liu R; Wang T; Zhang B; Qin L; Wu C; Li Q; Ma L
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):252-8. PubMed ID: 25515572
[TBL] [Abstract][Full Text] [Related]
24. Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT).
Kelly D; Nolan JM; Howard AN; Stack J; Akuffo KO; Moran R; Thurnham DI; Dennison J; Meagher KA; Beatty S
Br J Nutr; 2017 Jan; 117(1):108-123. PubMed ID: 28122649
[TBL] [Abstract][Full Text] [Related]
25. Contrast Sensitivity and Lateral Inhibition Are Enhanced With Macular Carotenoid Supplementation.
Stringham JM; O'Brien KJ; Stringham NT
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2291-2295. PubMed ID: 28431432
[TBL] [Abstract][Full Text] [Related]
26. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
Obana A; Tanito M; Gohto Y; Okazaki S; Gellermann W; Bernstein PS
PLoS One; 2015; 10(10):e0139257. PubMed ID: 26451726
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
[TBL] [Abstract][Full Text] [Related]
28. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial.
Loughman J; Loskutova E; Butler JS; Siah WF; O'Brien C
Ophthalmol Sci; 2021 Sep; 1(3):100039. PubMed ID: 36247822
[TBL] [Abstract][Full Text] [Related]
29. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
30. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.
Beatty S; Chakravarthy U; Nolan JM; Muldrew KA; Woodside JV; Denny F; Stevenson MR
Ophthalmology; 2013 Mar; 120(3):600-606. PubMed ID: 23218821
[TBL] [Abstract][Full Text] [Related]
31. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
[TBL] [Abstract][Full Text] [Related]
32. Clinical Effects of Dietary Supplementation of Lutein with High Bio-Accessibility on Macular Pigment Optical Density and Contrast Sensitivity: A Randomized Double-Blind Placebo-Controlled Parallel-Group Comparison Trial.
Machida N; Kosehira M; Kitaichi N
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998324
[TBL] [Abstract][Full Text] [Related]
33. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS.
Nolan JM; Loughman J; Akkali MC; Stack J; Scanlon G; Davison P; Beatty S
Vision Res; 2011 Mar; 51(5):459-69. PubMed ID: 21237188
[TBL] [Abstract][Full Text] [Related]
34. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
Aleman TS; Cideciyan AV; Windsor EA; Schwartz SB; Swider M; Chico JD; Sumaroka A; Pantelyat AY; Duncan KG; Gardner LM; Emmons JM; Steinberg JD; Stone EM; Jacobson SG
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1319-29. PubMed ID: 17325179
[TBL] [Abstract][Full Text] [Related]
35. Effects of Macuprev
Parravano M; Tedeschi M; Manca D; Costanzo E; Di Renzo A; Giorno P; Barbano L; Ziccardi L; Varano M; Parisi V
Adv Ther; 2019 Sep; 36(9):2493-2505. PubMed ID: 31243641
[TBL] [Abstract][Full Text] [Related]
36. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
[TBL] [Abstract][Full Text] [Related]
38. Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.
Nolan JM; Loskutova E; Howard AN; Moran R; Mulcahy R; Stack J; Bolger M; Dennison J; Akuffo KO; Owens N; Thurnham DI; Beatty S
J Alzheimers Dis; 2014; 42(4):1191-202. PubMed ID: 25024317
[TBL] [Abstract][Full Text] [Related]
39. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Nolan JM; Stack J; O'connell E; Beatty S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
